Launch of Accelerated Bookbuild and Subscription

Further to the Company's announcement on 3 September 2026, Kazera Global plc (AIM: KZG), announces a proposed Placing (the "Placing") and Subscription (the "Subscription") (together the "Fundraising") to raise gross proceeds of approximately £500,000, through the issue of c.25,000,000 new ordinary shares in the capital of the Company (the "New Ordinary Shares") at a price of 2 pence per New Ordinary Share (the "Issue Price").

The Placing will be conducted by way of an accelerated book build (the "Bookbuild") which will be launched immediately following this announcement. The Fundraising is conditional upon, amongst other things, the passing of the resolutions at the General Meeting of the Company convened for 10.00 a.m. on 21 September 2026.

Summary

• The Company intends to raise approximately £500,000 pursuant to the Placing and Subscription (further details outlined below)
• The net proceeds from the Fundraising are intended to further strengthen the Company's balance sheet and provide a dedicated pool of investment capital, giving the Company additional flexibility both to support its existing investments where appropriate and to pursue value-accretive opportunities in the critical minerals and wider resources and energy sectors.
• The Fundraising follows the grant of the Mining Right over Sea Concession 2A and the recently announced settlement with Fujax, which the Board believes have materially strengthened the Company's position.
• In addition to the Fundraising, Geoffrey Eyre, a Director and Non-Executive Chairman of the Company, has indicated his intention to satisfy accrued fees by the issue of new Ordinary Shares at the Issue Price, while an aggregate of £62,000 owed to a supplier and a consultant is intended to also be satisfied through the issue of new Ordinary Shares at the Issue Price.
• The Existing Ordinary Shares remain temporarily suspended from trading on AIM during the Capital Access Window. The Company expects to announce the outcome of the Fundraising as soon as practicable following completion of the Bookbuild, after which trading in the Existing Ordinary Shares is expected to resume.
• The Issue Price is 2 pence per Ordinary Share, which represents a premium of approximately 2.6 per cent. to the closing mid-market price of 1.95 pence per Ordinary Share on 2 September 2026, being the last trading day prior to the commencement of the Capital Access Window.
• Completion of the Fundraising is expected to take place on or around 22 September 2026, subject to, and following, the passing of the Resolutions at the General Meeting.

The Fundraising

The Fundraising will comprise:

• a placing to raise gross proceeds of approximately £250,000 (the "Placing") through the issue of c.12,500,000 new Ordinary Shares (the "Placing Shares") at the Issue Price; and
• a subscription to raise gross proceeds of approximately £250,000 (the "Subscription") through the issue of c.12,500,000 new Ordinary Shares (the "Subscription Shares").

The Company has also received an indication of interest from a potential investor in relation to a further direct subscription of approximately £220,000 at the Issue Price. The potential subscription may not be concluded prior to the close of the Bookbuild and, accordingly, the Company may accept such subscription following the close of the Bookbuild and prior to Admission. No binding commitment has yet been entered into and there can be no certainty that the potential subscription will proceed. If concluded, the additional subscription will form part of the Fundraising and a further announcement will be made.

As set out above, the issuance of the Placing Shares and Subscription Shares will be conditional (amongst other things) on the passing of the Resolutions to be proposed at the General Meeting of the Company to be held on 21 September 2026 (or any adjournment thereof) which will renew the Company's authority to disapply statutory pre-emption rights and issue shares on a non-pre-emptive basis for cash.

Zeus is acting as sole broker in connection with the Placing. The Placing will be conducted by way of an accelerated bookbuild, which will be launched immediately following this Announcement, in accordance with the terms and conditions set out in Appendix III to this Announcement. A further announcement confirming the closing of the Bookbuild, the number of New Ordinary Shares to be issued pursuant to the Placing and Subscription, the conclusion of the Capital Access Window and the expected timing for the resumption of trading in the Existing Ordinary Shares will be made in due course.

The Placing is conditional upon (amongst other things) the Placing Agreement not having been terminated prior to Admission. The Placing is not conditional on a minimum amount being raised.

The expected timetable of principal events is set out in Appendix I to this Announcement.

Persons who have chosen to participate in the Placing, by making an oral or written offer to acquire Placing Shares, will be deemed to have read and understood this Announcement in its entirety (including the Appendices) and to be making such offer on the terms and subject to the conditions herein, and to be providing the representations, warranties, agreements, acknowledgements and undertakings contained in Appendix III.

The Company announces that it is seeking to raise gross proceeds of approximately £500,000 by way of the Fundraising, comprising the Placing and the Subscription. The net proceeds of the Fundraising will further strengthen the Company's balance sheet and provide a dedicated pool of investment capital, giving the Company additional flexibility both to support the development of its existing investments where appropriate and to pursue value-accretive new investment opportunities in accordance with its investing policy.

The Company will require share authorities to issue and allot the New Ordinary Shares to be issued pursuant to the Fundraising. Accordingly, the Placing and Subscription are each conditional, inter alia, upon Shareholders approving the Resolutions at the General Meeting, to be convened on 21 September 2026.

Admission of the New Ordinary Shares is expected to occur at 8.00 a.m. on 22 September 2026 (or such later time and/or date as Zeus and the Company may agree, not being later than 30 October 2026). The Placing Shares and Subscription Shares will rank pari passu in all respects with the existing Ordinary Shares and will rank in full for all dividends and other distributions declared, made or paid on the Ordinary Shares after Admission.

Background to, and reasons for, the Fundraising

Kazera Global plc is an AIM-quoted investment company which seeks to achieve shareholder returns primarily through capital appreciation from the purchase and sale of securities and direct investments in companies and projects in Africa, within the mining and resource sectors. The Company's current operating portfolio comprises Deep Blue Minerals (Pty) Ltd, an alluvial diamond operation at Alexander Bay in the Northern Cape, South Africa, and Whale Head Minerals (Pty) Ltd, a heavy mineral sands operation in the same area producing garnet, ilmenite, zircon and rutile.

In July 2026 the Company entered into a long-term strategic partnership with South Africa AT Investments ("SAI") for the development of WHM's heavy mineral sands interests. Under the arrangement, SAI is responsible for funding and executing mining operations, including all capital and operating costs, with WHM retaining a 20 per cent. cost free entitlement to production. WHM received an initial US$750,000 advance against future sales from SAI in July 2026 and, following the grant of the Mining Right over Sea Concession 2A announced on 2 September 2026, a further US$1.75 million will become payable following formal execution of the Mining Right. Commercial production from 2A is targeted for Q1 2027, ramping to an anticipated minimum of 10,000 tonnes per month of concentrate by Q2 2027, with a progressive ramp-up to 30,000 tonnes of concentrate per month.

The grant of the 2A Mining Right represents a significant milestone for the Company and provides the platform for the phased development of 2A with SAI. The independent Technical Report published on 24 August 2026 confirmed an Inferred Mineral Resource containing approximately 1.31 million tonnes of economic heavy minerals within an Evaluation Area representing just 1.42 per cent. of the 2A licence area, with an indicative gross in-situ value of approximately US$369.3 million. The remaining 98.58 per cent. of 2A has been identified as a substantial Geological Target which, on the conservative basis set out in the Technical Report, is estimated to contain an additional 265.2 million tonnes of HMS, with grades yet to be determined.

On 3 September 2026, the Company announced that, without any admission of liability, it had agreed terms for the full and final settlement of amounts claimed by Fujax South Africa (Pty) Ltd ("Fujax") under historic prepayment arrangements with WHM. The US$1.0 million settlement comprises US$500,000 to be satisfied through the issue of new Ordinary Shares and US$500,000 payable in cash by way of instalments through to 1 March 2027. The Board considers the settlement to represent a positive resolution of a historic liability, materially reducing the associated cash burden on the Company while simplifying the contractual arrangements surrounding WHM as it moves into the next stage of its development following the grant of the 2A Mining Right and its commercial arrangement with SAI.

Separately, following the arbitration award made in the Company's favour in May 2025 in relation to the disposal of African Tantalum (Pty) Ltd ("Aftan"), the Company has agreed settlement arrangements with Hebei Xinjian Construction CC. Under those arrangements, up to US$10.5 million is payable to the Company, with provision for the settlement to be satisfied in full upon receipt of US$9.0 million by 31 December 2026. As announced on 24 July 2026, the Board intends, subject to legal, tax, working capital and regulatory considerations, to return approximately 80 per cent. of the net cash proceeds of that settlement to qualifying Shareholders under the proposed Aftan Shareholder Return Programme.

Against this backdrop, the Board believes Kazera is entering a materially strengthened phase of its development.

The Company's existing cash resources are sufficient for its present requirements. However, as an investing company, the Board believes that maintaining a strong corporate cash position provides an important strategic advantage, enabling Kazera both to support the development of its existing investments where appropriate and to act quickly when attractive new investment opportunities arise.

The net proceeds of the Fundraising are therefore intended to further strengthen the Company's balance sheet and create a dedicated pool of investment capital for deployment across the Company's interests and into value-accretive new opportunities in accordance with its investing policy. The Directors believe that having capital available at the point of negotiation should enhance the Company's ability to secure such opportunities on attractive terms.

Details of the Fundraising

Subject to the satisfaction of the conditions in respect of the Fundraising including, inter alia, the passing of the Resolutions, the Company intends to issue up to c.25,000,000 New Ordinary Shares at the Issue Price to raise gross proceeds of £500,000, before expenses.

The Issue Price represents a premium of approximately 2.6 per cent. to the closing mid-market price of 1.95 pence per Ordinary Share on 2 September 2026, being the last trading day prior to the commencement of the Capital Access Window.

Details of the Placing

The Placing comprises the placing of approximately c.12,500,000 new Ordinary Shares at the Issue Price. The Placing will raise approximately £500,000 before expenses. The Placing is conditional, inter alia, upon Shareholders approving the Resolutions at the General Meeting, compliance by the Company in all material respects with its obligations under the Placing Agreement and the occurrence of Admission.

Pursuant to the terms of the Placing Agreement, Zeus, as agent for the Company, has agreed to use its reasonable endeavours to procure subscribers for the Placing Shares at the Issue Price. The Placing is not underwritten and is not conditional on a minimum amount being raised.

Details of the Subscription

The Subscription comprises the issue of approximately c.12,500,000 new Ordinary Shares at the Issue Price. The Subscription is conditional, inter alia, upon Shareholders approving the Resolutions at the General Meeting, on the close of the Placing, Admission occurring and the Placing Agreement not being terminated prior to Admission.

The Subscription Shares will be subscribed for on the basis agreed pursuant to subscription agreements between the Company and the relevant subscribers, rather than pursuant to the terms and conditions of the Placing contained in the Appendix III to this Announcement.

Other Share Issuances

In addition to the Fundraising, Geoff Eyre, a Director and Non-Executive Chairman of the Company, has indicated his intention to satisfy £26,083.33 of accrued but unpaid fees by the issue of new Ordinary Shares at the Issue Price (the "Fee Shares"). The final amount to be satisfied and the resulting number of Fee Shares will be confirmed in the announcement of the results of the Fundraising.

One supplier and one consultant to the Company have also indicated they will accept satisfaction of an aggregate of £62,000 owed to them by the Company through the issue of 3,100,000 new Ordinary Shares at the Issue Price (the "Creditor Shares").

Subject to these arrangements being finalised, the issue of the Fee Shares and Creditor Shares will be conditional upon, inter alia, the passing of the Resolutions at the General Meeting and Admission. Neither the Fee Shares nor the Creditor Shares will generate cash proceeds for the Company and will not form part of the gross proceeds of the Fundraising.

Settlement and dealings

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of their issue.

Application(s) will be made to the London Stock Exchange for admission of the Placing Shares and Subscription Shares to trading on AIM. It is expected that Admission of the New Ordinary Shares will take place at 8.00 a.m. on or around 22 September 2026 and that dealings in the New Ordinary Shares on AIM will commence at the same time.

It is expected that CREST accounts will be credited with entitlements to the New Ordinary Shares as soon as practicable after 8.00 a.m. on the day of Admission and that share certificates (where applicable) will be despatched as soon as practicable after, and in any event within 14 days of, Admission.

The New Ordinary Shares, assuming completion of the Placing and the Subscription, represent approximately 2 per cent. of the Existing Ordinary Shares, and approximately 2 per cent. of the Enlarged Share Capital.

Use of proceeds

The net cash proceeds of the Fundraising are expected to be approximately £480,000.

The net proceeds will be used to further strengthen the Company's balance sheet and provide a dedicated pool of investment capital, giving the Company additional flexibility both to support its existing investments where appropriate and to pursue value-accretive opportunities in the critical minerals and wider resources and energy sectors.

APPENDIX I

Expected Timetable for the Fundraising

2026

Notes:

• References to times in this announcement are to London time (unless otherwise stated).

APPENDIX II

Definitions

The following definitions apply throughout this Announcement unless the context otherwise requires:

APPENDIX III

EEA product governance

UK product governance

Details of the Placing Agreement and the Placing Shares

The New Ordinary Shares will trade on AIM under KZG with ISIN GB00B830HW33.

Application for admission to trading

Application will be made to London Stock Exchange for admission to trading of the Placing Shares on AIM.

It is expected that Admission of the Placing Shares will take place on or before 22 September 2026 and that dealings in the Placing Shares on AIM will commence at the same time.

Bookbuild

Zeus will today commence the Bookbuild to determine demand for participation in the Placing by potential Placees at the Issue Price. This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. No commissions will be paid to Placees or by Placees in respect of any Placing Shares.

Participation in, and principal terms of, the Placing

• Zeus is arranging the Placing as agent for the Company.
• Participation in the Placing is only available to persons who are lawfully able to be, and have been, invited to participate by Zeus. Zeus is entitled to participate in the Placing as principal.
• The Bookbuild will establish the number of Placing Shares to be placed at the Issue Price.

Conditions of the Placing

• the Resolutions having been duly passed without amendment at the General Meeting;
• the issue and allotment of the New Ordinary Shares, conditional only upon Admission;
• Admission occurring by no later than 8.00 a.m. (London time) on 22 September 2026 or such other date and time as may be agreed between the Company and the Bookrunner, not being later than 8.00 am (London time) on 30 October 2026 (the "Long Stop Date"); and
• the Placing Agreement not having been terminated by the Bookrunner in accordance with its terms.

Right to terminate the Placing Agreement

• the Company is in breach of any of its obligations under the Placing Agreement or any applicable law or regulation in respect of the Placing;
• any of the warranties given in the Placing Agreement is or becomes untrue or inaccurate or misleading;
• there occurs or arises prior to Admission any significant change or new material matter which the Bookrunner determines should be notified to Placees or Shareholders;
• an event of force majeure occurs which, in the good faith opinion of the Bookrunner, would prevent any party from performing its obligations under the Placing Agreement;
• the Bookrunner becomes aware there has been, or is reasonably likely to occur, any material adverse change in any national or international political, military, diplomatic, economic, financial or market conditions (including disruption to trading on any relevant stock exchange) or currency exchange rates or exchange controls or any statutory or regulatory matter which would have or be likely to have a material and adverse effect on the Placing or Admission or otherwise render the Placing or Admission temporarily or permanently impracticable or inadvisable; or

No Admission Document or Prospectus

The Placing Shares are being offered to a limited number of specifically invited persons only and have not been nor will be offered in such a way as to require the publication of an admission document or prospectus in the United Kingdom or in any other jurisdiction. No offering document, admission document or prospectus has been or will be submitted to be approved by the FCA in relation to the Placing, and Placees' commitments will be made solely on the basis of the information contained in the Announcement (including this Appendix),the business and financial information that the Company is required to publish in accordance with the AIM Rules and the Market Abuse Regulation and any information announced through a Regulatory Information Service by or on behalf of the Company on or prior to the date of this Announcement (the "Exchange Information").

Registration and Settlement

Following the close of the Bookbuild, each Placee allocated Placing Shares in the Placing will be sent a trade confirmation or contract note in accordance with the standing arrangements in place with Zeus, stating the number of Placing Shares allocated to it at the Issue Price, the aggregate amount owed by such Placee (in GBP) and a form of confirmation in relation to settlement instructions.

Settlement of transactions in the Placing Shares (ISIN: GB00B830HW33) following Admission, will take place within the system administered by Euroclear UK & International Limited ("CREST") provided that, subject to certain exceptions, Zeus reserve the right to require settlement for, and delivery of, the Placing Shares (or a portion thereof) to Placees by such other means that it deems necessary if delivery or settlement is not possible or practicable within CREST within the timetable set out in this Announcement or would not be consistent with the regulatory requirements in any Placee's jurisdiction.

It is expected that settlement will be on the date of Admission in accordance with the instructions set out in the form of confirmation.

Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of two percentage points above SONIA.

Representations, Warranties and Further Terms

7. that it has made its own assessment of the Placing Shares and has relied on its own investigation of the business, financial or other position of the Company in accepting a participation in the Placing and neither Zeus nor the Company or any of their respective affiliates, agents, directors, officers or employees or any person acting on behalf of any of them has provided, and will not provide, it with any material regarding the Placing Shares or the Company or any other person other than the information in this Announcement or the Exchange Information; nor has it requested Zeus, the Company or any of their respective affiliates, agents, directors, officers or employees or any person acting on behalf of any of them to provide it with any such information;

• that the only information on which it is entitled to rely on and on which it has relied in committing to subscribe for the Placing Shares is contained in the Announcement and Exchange Information, such information being all that it deems necessary to make an investment decision in respect of the Placing Shares and it has made its own assessment of the Company, the Placing Shares and the terms of the Placing based on the Announcement and Exchange Information;
• that neither Zeus nor the Company or any of their respective affiliates, agents, directors, officers or employees has made any representation or warranty to it, express or implied, with respect to the Company, the Placing or the Placing Shares or the accuracy, completeness or adequacy of the Exchange Information;
• that it will (or will procure that its nominee will) if applicable, make notification to the Company of the interest in its New Ordinary Shares in accordance with the Disclosure Guidance and Transparency Rules published by the FCA;
• that it will indemnify and hold the Company and Zeus and their respective affiliates harmless from any and all costs, claims, liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings in this Appendix and further agrees that the Company and Zeus will rely on the truth and accuracy of the confirmations, warranties, acknowledgements and undertakings herein and, if any of the foregoing is or becomes no longer true or accurate, the Placee shall promptly notify Zeus and the Company. All confirmations, warranties, acknowledgements and undertakings given by the Placee, pursuant to this Announcement (including this Appendix) are given to Zeus for themselves and on behalf of the Company and will survive completion of the Placing and the Admission;
• that time shall be of the essence as regards its obligations pursuant to this Appendix;
• that (i) it has complied with its obligations under the Criminal Justice Act 1993, the Market Abuse Regulation, (ii) in connection with money laundering and terrorist financing, it has complied with its obligations under the Proceeds of Crime Act 2002 (as amended), the Terrorism Act 2000 (as amended), the Terrorism Act 2006 and the Money Laundering, Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (as amended) and (iii) it is not a person: (a) with whom transactions are prohibited under the Foreign Corrupt Practices Act of 1977 or any economic sanction programmes administered by, or regulations promulgated by, the Office of Foreign Assets Control of the U.S. Department of the Treasury; (b) named on the Consolidated List of Financial Sanctions Targets maintained by HM Treasury of the United Kingdom; or (c) subject to financial sanctions imposed pursuant to a regulation of the European Union or a regulation adopted by the United Nations (together, the "Regulations"); and, if making payment on behalf of a third party, that satisfactory evidence has been obtained and recorded by it to verify the identity of the third party as required by the Regulations and it has obtained all governmental and other consents (if any) which may be required for the purpose of, or as a consequence of, such purchase, and it will provide promptly to Zeus such evidence, if any, as to the identity or location or legal status of any person which Zeus may request from it in connection with the Placing (for the purpose of complying with such Regulations or ascertaining the nationality of any person or the jurisdiction(s) to which any person is subject or otherwise) in the form and manner requested by Zeus on the basis that any failure by it to do so may result in the number of Placing Shares that are to be subscribed for by it or at its direction pursuant to the Placing being reduced to such number, or to nil, as Zeus may decide in its absolute discretion;

When a Placee or person acting on behalf of the Placee is dealing with Zeus, any money held in an account with Zeus on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money within the meaning of the rules and regulations of the FCA made under the FSMA. The Placee acknowledges that the money will not be subject to the protections conferred by the client money rules; as a consequence, this money will not be segregated from Zeus's money in accordance with the client money rules and will be used by Zeus in the course of its own business; and the Placee will rank only as a general creditor of Zeus.

Time is of the essence as regards each Placee's obligations under this Appendix.